RESEARCH NEWS
FDA Approves First Generic Under-the-Tongue Suboxone
 

(HealthDay News) The first generic version of an under-the-tongue film to treat opioid addiction has been approved by the FDA. The generic version of Suboxone (buprenorphine and naloxone) film from Mylan Technologies Inc. and Dr. Reddy’s Laboratories SA will be available in different strengths. The brand name and generic films may only be prescribed by Drug Addiction Treatment Act-certified prescribers, the FDA said.


Mon, 18 Jun 2018 PAIN MANAGEMENT
Cleared Blood Glucose Monitor Systems Not Always Accurate
 

(HealthDay News) One in three commercially available blood glucose monitor systems (BGMs) meet a predefined accuracy standard, research in Diabetes Care finds. Researchers recruited 1,035 subjects to have blood glucose measured on six different systems plus a reference lab sample. BGMs were obtained from consumer outlets and tested in three triple-blinded studies. The accuracy standard was not met in any of the studies.


Mon, 18 Jun 2018 ENDOCRINOLOGY
Kellogg’s Honey Smacks Cereal Recalled Due to Salmonella Risk
 

The Kellogg Company has announced it is recalling certain boxes of Honey Smacks cereal due to the possibility of contamination with Salmonella. According to CDC, 73 illnesses potentially tied to contaminated cereal have been reported across 31 states from March 3 through May 28. Twenty-four people have been hospitalized, but no deaths have been reported. The cereal under recall includes Honey Smacks 15.3 oz. size with a UPC code of 3800039103 and the 23 oz. size with a UPC code of 3800014810.


Mon, 18 Jun 2018 BREAKING NEWS
Cannabis Use Linked to Psychosis Symptoms in Adolescents
 

Cannabis use is associated with psychosis symptoms (PS) during adolescence, a research letter in JAMA Psychiatry suggests. Researchers examined year-to-year associations between cannabis use and PS over four years among 3,720 adolescents. Statistically significant positive cross-lagged associations were revealed at every time point from cannabis use to PS reported 12 months later, exceeding the random intercepts of cannabis use and PS. There was a statistically significant association for PS at age 15 with cannabis use at age 16.


Mon, 18 Jun 2018 BREAKING NEWS
Walk Test IDs Risk of Cognitive Dysfunction Post Cardiac Surgery
 

(HealthDay News) The six-minute walk distance (6MWD) test is useful in identifying patients with a higher likelihood of developing postoperative cognitive dysfunction (POCD) following cardiac surgery, research in the Annals of Thoracic Surgery suggests. The POCD group had a significantly lower 6MWD versus the non-POCD group. For each increase of 50 m in the 6MWD the odds of POCD decreased.


Mon, 18 Jun 2018 CARDIOLOGY
VTE Linked to Acute Decline in Physical Function in Women
 

For women, venous thromboembolism (VTE) is associated with acute decline in physical function, research in the Journal of Thrombosis and Haemostasis suggests. The researchers found a decline in physical function over four years comparing women with versus without incident VTE (multivariable-adjusted mean difference, −6.5 and −3.8 points in NHS and NHS II, respectively). Women specifically reporting a pulmonary embolism had a greater difference (difference, −7.4 and −4.8 for NHS and NHS II, respectively), equivalent to 6.2 years of aging.


Mon, 18 Jun 2018 BREAKING NEWS